Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,990.00
-110.00 (-2.68%)
At close: Nov 19, 2025
-2.68%
Market Cap86.75B
Revenue (ttm)111.60B
Net Income (ttm)4.44B
Shares Out21.74M
EPS (ttm)117.00
PE Ratio34.10
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume98,797
Average Volume140,556
Open4,100.00
Previous Close4,100.00
Day's Range3,965.00 - 4,125.00
52-Week Range3,090.00 - 5,150.00
Beta0.55
RSI47.09
Earnings DateNov 14, 2025

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements

News

There is no news available yet.